Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Sep;47(9):e788.
doi: 10.1097/CCM.0000000000003813.

Immune Checkpoint Inhibitor Use in Sepsis: Monitoring Immune Checkpoint Inhibitor Toxicity

Karthik Suresh  1 , Franco D'Alessio
Affiliations
Comment

Immune Checkpoint Inhibitor Use in Sepsis: Monitoring Immune Checkpoint Inhibitor Toxicity

Karthik Suresh et al. Crit Care Med. 2019 Sep.
No abstract available

PubMed Disclaimer

Comment in

  • The authors reply.
    Hotchkiss RS, Yende S, Angus DC, Moldawer LL, Crouser E, Martin G, Coopersmith CM, Brakenridge S, Mayr FB, Park PK. Hotchkiss RS, et al. Crit Care Med. 2019 Sep;47(9):e788-e789. doi: 10.1097/CCM.0000000000003887. Crit Care Med. 2019. PMID: 31415323 No abstract available.

Comment on

References

    1. Hotchkiss RS, Colston E, Yende S, et al. Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 (BMS-936559). Crit Care Med. February 2019:1. doi:10.1097/CCM.0000000000003685 - DOI - PMC - PubMed
    1. Suresh K, Voong KR, Shankar B, et al. Pneumonitis in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors. J Thorac Oncol. 2018;13(12). doi:10.1016/j.jtho.2018.08.2035 - DOI - PubMed
    1. Khunger M, Rakshit S, Pasupuleti V, et al. Incidence of pneumonitis with use of PD-1 and PD-L1 inhibitors in non-small cell lung cancer: A Systematic Review and Meta-analysis of trials. Chest. 2017. doi:10.1016/j.chest.2017.04.177 - DOI - PubMed
    1. Naidoo J Pneumonitis in patients treated with anti-programmed Death-1/programmed death ligand 1 therapy. J Clin Oncol. 2017;35. doi:10.1200/jco.2016.68.2005 - DOI - PMC - PubMed
    1. Cho JY, Kim J, Lee JS, et al. Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer. Lung Cancer. 2018;125:150–156. doi:10.1016/j.lungcan.2018.09.015 - DOI - PubMed